Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-CMOP vs R-CHOP in Low/Medium-Risk DLBCL
NCT06760039Phase 2Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2025
- Primary completion
- Aug 2028
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of mitoxantrone hydrochloride liposome in diffuse large B-cell lymphoma (DLBCL), sponsored by Sun Yat-sen University. Started Jan 2025; status: recruiting.
02
Drugs
mitoxantrone hydrochloride liposome
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT06760039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06760039.